With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.112881-51-3,4′-(4-Pyridyl)-2,2′:6′,2”-terpyridine,as a common compound, the synthetic route is as follows.
Cd(NO3)2¡¤4H2O (123mg, 0.4mmol),4?-(4-pyridyl)-2.2?:6?,2??-terpyridine (31 mg, 0.1 mmol) were added to a mixture ofH2O (5 mL) and DMF (1 mL). The slurry was then transferred into a 23 mL Teflonlinedautoclave and heated at 110 C for 48 h. The solution was allowed to cool at arate of 5 C/h to room temperature. Neddle-shaped crystals were collected throughfiltration, washed with H2O (3 ¡Á 20mL) and EtOH(3 ¡Á 20 mL), dried at roomtemperaturein a vacuum(47 mg, 85% yield based on PYTPY). IR (KBr): nu=3455 (vw),3060 (w), 2800 (vw), 1600 (vs), 1450 (vs), 1378 (vs), 1291 (vs), 1166 (m), 1080(w), 1007 (m), 894 (w), 835 (w), 789 (m), 723 (w), 650 (m), 583 (vw), 498(w) cm-1. C21H17CdN5O6 (M = 547.80): calcd. C 45.90%, H3.120%, N 12.75%;found: C 45.76%, H3.143%, N 12.96%., 112881-51-3
The synthetic route of 112881-51-3 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Yuan, Lijun; Fu, Zhiyong; Inorganic Chemistry Communications; vol. 69; (2016); p. 66 – 69;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI